文献速递角膜与眼表疾病

异鼠李素通过降低真菌负荷及抑制模式识别受体与炎性因子改善烟曲霉菌性角膜炎

Isorhamnetin Ameliorates Aspergillus fumigatus Keratitis by Reducing Fungal Load, Inhibiting Pattern-Recognition Receptors and Inflammatory Cytokines.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

本研究探讨天然黄酮类化合物异鼠李素对小鼠烟曲霉菌性角膜炎的抗真菌与抗炎作用。体外实验显示异鼠李素在80 µg/mL浓度下不影响细胞活力,可抑制烟曲霉菌分生孢子生长及菌丝活性,破坏菌丝形态与膜完整性。体内实验表明异鼠李素治疗可减轻角膜炎严重程度,降低角膜真菌负荷及中性粒细胞募集,并下调TLR-2、TLR-4、Dectin-1、IL-1β及TNF-α的表达。

要点

  • 异鼠李素在80 µg/mL浓度下抑制烟曲霉菌生长且不影响角膜上皮细胞及巨噬细胞活力。
  • 异鼠李素破坏烟曲霉菌菌丝形态与细胞膜完整性,发挥抗真菌作用。
  • 异鼠李素通过下调TLR-2、TLR-4、Dectin-1及IL-1β、TNF-α减轻角膜炎炎症反应。

核心结论

  • 异鼠李素通过抑制烟曲霉菌生长、减少中性粒细胞募集及下调炎性因子,改善小鼠烟曲霉菌性角膜炎预后。

研究设计与样本

  • 体外实验采用人角膜上皮细胞(HCECs)与RAW264.7细胞评估异鼠李素最低有效浓度及细胞毒性。
  • 体内实验采用小鼠烟曲霉菌性角膜炎模型,评估异鼠李素抗真菌与抗炎效果。

主要发现

  • 在HCECs与RAW264.7细胞中,异鼠李素于80 µg/mL浓度下显著抑制烟曲霉菌分生孢子生长及菌丝活性,且不影响细胞活力。
  • 体外实验中异鼠李素改变烟曲霉菌菌丝形态及膜完整性。
  • 小鼠烟曲霉菌性角膜炎模型中,异鼠李素治疗降低角膜真菌负荷并抑制中性粒细胞募集,减轻角膜炎严重程度。
  • 体内与体外实验中,异鼠李素处理组TLR-2、TLR-4、Dectin-1、IL-1β及TNF-α的mRNA与蛋白表达水平均显著降低。

临床怎么用

  • 异鼠李素可能作为烟曲霉菌性角膜炎的潜在辅助治疗药物,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Isorhamnetin is a natural flavonoid with both antimicrobial and anti-inflammatory properties, but its effect on fungal keratitis (FK) remains unknown. The current study aims to investigate the antifungal and anti-inflammatory effects of isorhamnetin against mouse Aspergillus fumigatus keratitis. METHODS: In vitro, the lowest effective concentration of isorhamnetin was assessed by minimum inhibitory concentration and cytotoxicity tests in human corneal epithelial cells (HCECs) and RAW264.7 cells. The antifungal property was investigated by scanning electron microscopy and propidium iodide uptake test. The anti-inflammatory effect of isorhamnetin in HCECs and RAW264.7 cells was observed by quantitative real-time polymerase chain reaction (qRT-PCR). In the eyes of mice with A. fumigatus keratitis, FK severity was evaluated using clinical score, plate counting, histological staining and periodic acid Schiff staining. In vivo, the anti-inflammatory effect of isorhamnetin was examined by immunofluorescence staining, myeloperoxidase assay, Western blot, enzyme-linked immunosorbent assay, and qRT-PCR. RESULTS: In HCECs and RAW264.7 cells, isorhamnetin significantly inhibited A. fumigatus conidia growth and hyphae viability at 80 µg/mL without affecting cell viability. In vitro, isorhamnetin altered A. fumigatus hyphal morphology and membrane integrity. In A. fumigatus keratitis mouse model, isorhamnetin treatment alleviated the severity of FK by reducing corneal fungal load and inhibiting neutrophil recruitment. In addition, the mRNA and protein expression levels of TLR-2, TLR-4, Dectin-1, IL-1β, and tumor necrosis factor-α were significantly decreased in isorhamnetin-treated groups in vivo and in vitro. CONCLUSIONS: Isorhamnetin improves the prognosis of A. fumigatus keratitis in mice by inhibiting the growth of A. fumigatus, reducing the recruitment of neutrophils and downregulating inflammatory factors.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tian X, Peng X, Lin J, et al. Isorhamnetin Ameliorates Aspergillus fumigatus Keratitis by Reducing Fungal Load, Inhibiting Pattern-Recognition Receptors and Inflammatory Cytokines. Invest Ophthalmol Vis Sci. 2021. PMID: 33783487. doi:10.1167/iovs.62.3.38

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。